Novartis Recalls NeoCitran Extra Strength Powder Packets Due to Foreign Substances
Novartis Consumer Health is recalling NeoCitran Extra Strength powder packets because they may contain foreign substances. The products were distributed nationwide and internationally.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product could cause temporary or medically reversible health consequences. The presence of foreign substances is a potential hazard, but no specific injuries or illnesses are reported in the source text, placing it in the moderate range rather than high or severe.
Plain-English summary
Novartis Consumer Health is voluntarily recalling specific lots of NeoCitran Extra Strength powder packets, Soothing Lemon flavor. The recall is being conducted because the products may contain foreign substances.
The affected products are labeled as either NeoCitran Extra Strength Nighttime Total 7 Symptom Relief or NeoCitran Extra Strength Cough, Cold & Flu. The recall covers 10-single dose pouches per carton. Specific lot numbers and expiration dates are listed in the official recall notice.
The products were distributed nationwide in the United States, as well as in Mexico, Russia, Korea, Panama, China, and Canada. Consumers should stop using the recalled products and check their lot numbers against the official list to determine if they are affected.
The recalled product
- Product
- NeoCitran Extra Strength (acetaminophen 650 mg, pseudoephedrine hydrochloride 60 mg, dextromethorphan hydrobromide 20mg, chlorpheniramine maleate 4 mg, ascorbic acid 5 mg) powder packets, Soothing Lemon flavor, 10-single dose pouches per carton, Novartis Consumer Health Canada In
- Manufacturer
- Novartis Consumer Health
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 10094895
- Exp 7/31/2013
- 10098586
- Exp 9/30/2013
- 10104820
- Exp 12/31/2013
- 10109982
- Exp 2/28/2014
- 10110876
- Exp 3/31/2014
- 10114393
- Exp 5/31/2014
- 10119851
- Exp 7/31/2014
- 10122313
- Exp 9/30/2014
- b) 10097661
- Exp 8/31/2013
- 10099912
- 10105539
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Novartis Consumer Health
See all →- ModerateNovartis Recalls Benefiber Fiber Supplement Stick Packs Due to Consumer Complaints
FDA (Food) · 2014-03-05
- ModerateNovartis Recalls Theraflu Cold and Cough Powder Packets
FDA (Drugs) · 2014-01-29
- HighNovartis Recalls Theraflu Powder Packets Due to Foreign Substance Presence
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls Theraflu Exte Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
- SevereNovartis Recalls Theraflu Flu and Chest Congestion Powder Packets
FDA (Drugs) · 2014-01-29
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01